Gotowa bibliografia na temat „Immunological adjuvants”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Immunological adjuvants”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Immunological adjuvants"
Correa, Victor Araujo, Amanda Izeli Portilho i Elizabeth De Gaspari. "Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from Neisseria meningitidis". Diseases 10, nr 3 (19.07.2022): 46. http://dx.doi.org/10.3390/diseases10030046.
Pełny tekst źródłaMartiñón, Susana, Angel Cisneros, Sergio Villicaña, Ricardo Hernández-Miramontes, Edgar Mixcoha i Psyché Calderón-Vargas. "Chemical and Immunological Characteristics of Aluminum-Based, Oil-Water Emulsion, and Bacterial-Origin Adjuvants". Journal of Immunology Research 2019 (8.05.2019): 1–9. http://dx.doi.org/10.1155/2019/3974127.
Pełny tekst źródłaTrier, Nicole H., Esin Güven, Kristin Skogstrand, Evaldas Ciplys, Rimantas Slibinskas i Gunnar Houen. "Comparison of immunological adjuvants". APMIS 127, nr 9 (26.07.2019): 635–41. http://dx.doi.org/10.1111/apm.12976.
Pełny tekst źródłaHeath, A. W., i J. H. L. Playfair. "Cytokines as immunological adjuvants". Vaccine 10, nr 7 (styczeń 1992): 427–34. http://dx.doi.org/10.1016/0264-410x(92)90389-2.
Pełny tekst źródłaBorek, F. "Immunological adjuvants and vaccines". Journal of Immunological Methods 135, nr 1-2 (grudzień 1990): 293. http://dx.doi.org/10.1016/0022-1759(90)90286-5.
Pełny tekst źródłaStewart-Tull, D. "Symposium on immunological adjuvants". Vaccine 3, nr 2 (czerwiec 1985): 152–57. http://dx.doi.org/10.1016/0264-410x(85)90092-1.
Pełny tekst źródłaKim, Jeremiah Y., Matthew G. Rosenberger, Nakisha S. Rutledge i Aaron P. Esser-Kahn. "Next-Generation Adjuvants: Applying Engineering Methods to Create and Evaluate Novel Immunological Responses". Pharmaceutics 15, nr 6 (8.06.2023): 1687. http://dx.doi.org/10.3390/pharmaceutics15061687.
Pełny tekst źródłaYan, Yu, Dan Yao i Xiaoyu Li. "Immunological Mechanism and Clinical Application of PAMP Adjuvants". Recent Patents on Anti-Cancer Drug Discovery 16, nr 1 (25.05.2021): 30–43. http://dx.doi.org/10.2174/1574892816666210201114712.
Pełny tekst źródłaGolshan, Aneesa, i George Hui. "Uptake and activation profile of murine dendritic cells in response to stimulation with functionalized iron oxide nanoparticles". Journal of Immunology 204, nr 1_Supplement (1.05.2020): 91.20. http://dx.doi.org/10.4049/jimmunol.204.supp.91.20.
Pełny tekst źródłaIsraeli, E., N. Agmon-Levin, M. Blank i Y. Shoenfeld. "Adjuvants and autoimmunity". Lupus 18, nr 13 (30.10.2009): 1217–25. http://dx.doi.org/10.1177/0961203309345724.
Pełny tekst źródłaRozprawy doktorskie na temat "Immunological adjuvants"
O'Hagan, Derek Thomas. "Pharmaceutical formulations as immunological adjuvants". Thesis, University of Nottingham, 1987. http://eprints.nottingham.ac.uk/13211/.
Pełny tekst źródłaAlmeida, Antonio J. L. "Particulate carriers as immunological adjuvants". Thesis, Aston University, 1993. http://publications.aston.ac.uk/12609/.
Pełny tekst źródłaWhite, Karen Louise, i n/a. "Modified liposomes as adjuvants". University of Otago. School of Pharmacy, 2005. http://adt.otago.ac.nz./public/adt-NZDU20070126.131417.
Pełny tekst źródłaSvelander, Lena. "Studies on immunological mechanisms of induced arthritis in the rat /". Stockholm, 2002. http://diss.kib.ki.se/2002/91-7349-349-X/.
Pełny tekst źródłaFong, Long-yan, i 方朗茵. "Immunomodulatory properties of probiotic bacteria". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/208173.
Pełny tekst źródłapublished_or_final_version
Biological Sciences
Doctoral
Doctor of Philosophy
Gursel, Mayda. "Use of liposomes and cytokines as immunological adjuvants in vaccines". Thesis, University College London (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.338640.
Pełny tekst źródłaChan, Wing-keung. "The immunomodulatory effects of purified b-glucans and b-glucan containing herbs". Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/HKUTO/record/B39557996.
Pełny tekst źródłaChan, Wing-keung. "The immunomodulatory effects of purified [beta]-glucans and [beta]-glucan containing herbs /". View the Table of Contents & Abstract, 2007. http://sunzi.lib.hku.hk/hkuto/record/B38724674.
Pełny tekst źródłaCheung, Ka-wai, i 張嘉瑋. "The immunomodulatory effect of Brazilian green propolis and its uniquecompound Artepillin C". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B45900231.
Pełny tekst źródłaRoßmann, Laura [Verfasser]. "In-depth immunological analysis of prototypic adjuvants for vaccine formulations / Laura Roßmann". Mainz : Universitätsbibliothek der Johannes Gutenberg-Universität Mainz, 2020. http://d-nb.info/1223379299/34.
Pełny tekst źródłaKsiążki na temat "Immunological adjuvants"
Gregoriadis, Gregory, Anthony C. Allison i George Poste, red. Immunological Adjuvants and Vaccines. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4757-0283-5.
Pełny tekst źródłaNATO Advanced Study Institute on Immunological Adjuvants and Vaccines (1988 Ákra Soúnion, Greece). Immunological adjuvants and vaccines. New York: Plenum Press, 1989.
Znajdź pełny tekst źródłaGregory, Gregoriadis, McCormack Brenda, Allison Anthony C. 1925-, North Atlantic Treaty Organization. Scientific Affairs Division. i NATO Advanced Study Institute on Vaccines: New Generation Immunological Adjuvants (1994 : Akra Sounion, Greece), red. Vaccines: New generation immunological adjuvants. New York: Plenum Press, 1995.
Znajdź pełny tekst źródłaAlmeida, Anton io Jose Leitao das Neves. Particulate carriers as immunological adjuvants. Birmingham: Aston University. Department of Pharmaceutical Sciences, 1993.
Znajdź pełny tekst źródłaK, Gupta V. Immune-modulation & vaccine adjuvants. Houston, Tex: Studium Press LLC, 2010.
Znajdź pełny tekst źródłaP, Chow Paul N., Grant Cynthia A i Hinshalwood Anne M, red. Adjuvants and agrochemicals. Boca Raton, Fla: CRC Press, 1989.
Znajdź pełny tekst źródłaInternational, Congress on Neo-Adjuvant Chemotherapy (1st 1985 Paris France). Neo-adjuvant chemotherapy =: Chimiothérapie néo-adjuvante : proceedings of the first International Congress on Neo-Adjuvant Chemotherapy held in Paris (France), 6-9 November, 1985. London: Libbey, 1986.
Znajdź pełny tekst źródłaInternational, Congress on Neo-Adjuvant Chemotherapy (2nd Paris France). Neo-adjuvant chemotherapy =: Chimiothérapie néo-adjuvante : proceedings of the Second International Congress on Neo-Adjuvant Chemotherapy held in Paris (France), 19-21 February 1988. London: Libbey, 1988.
Znajdź pełny tekst źródła1945-, Benvenuto Antonio, red. Immunologic adjuvant research. Hauppauge, NY: Nova Science, 2009.
Znajdź pełny tekst źródłaIchiro, Azuma, i Jolles G, red. Immunostimulants: Now and tomorrow. Tokyo: Japan Scientific Societies Press, 1987.
Znajdź pełny tekst źródłaCzęści książek na temat "Immunological adjuvants"
Allison, Anthony C., i Noelene E. Byars. "Immunological Adjuvants". W Genetically Engineered Vaccines, 133–41. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3410-5_15.
Pełny tekst źródłaHeath, Andrew W. "Cytokines as Immunological Adjuvants". W Vaccine Design, 645–58. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1823-5_28.
Pełny tekst źródłaMohagheghpour, N., M. Dawson, P. Hobbs, A. Judd, R. Winant, L. Dousman, N. Waldeck i in. "Glucans as Immunological Adjuvants". W Advances in Experimental Medicine and Biology, 13–22. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1891-4_3.
Pełny tekst źródłaGregoriadis, Gregory. "Liposomes as Immunological Adjuvants". W Targeting of Drugs 3, 59–68. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-2938-5_7.
Pełny tekst źródłaAllison, Anthony C. "Antigens and Adjuvants for a New Generation of Vaccines". W Immunological Adjuvants and Vaccines, 1–12. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4757-0283-5_1.
Pełny tekst źródłaGregoriadis, Gregory, Lloyd Tan i Qifu Xiao. "The Immunoadjuvant Action of Liposomes: Role of Structural Characteristics". W Immunological Adjuvants and Vaccines, 79–94. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4757-0283-5_10.
Pełny tekst źródłavan Rooijen, Nico, i Donghui Su. "Immunoadjuvant Action of Liposomes: Mechanisms". W Immunological Adjuvants and Vaccines, 95–106. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4757-0283-5_11.
Pełny tekst źródłaSnippe, H., A. F. M. Verheul i J. E. G. van Dam. "Liposomal Vaccine to Streptococcus Pneumoniae Type 3 and 14". W Immunological Adjuvants and Vaccines, 107–22. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4757-0283-5_12.
Pełny tekst źródłaAlving, Carl R., Robert L. Richards, Michael D. Hayre, Wayne T. Hockmeyer i Robert A. Wirtz. "Liposomes as Carriers of Vaccines: Development of a Liposomal Malaria Vaccine". W Immunological Adjuvants and Vaccines, 123–31. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4757-0283-5_13.
Pełny tekst źródłaHunter, Robert L., Beth Bennett, Devery Howerton, Steve Buynitzky i Irene J. Check. "Nonionic Block Copolymer Surfactants as Immunological Adjuvants: Mechanisms of Action and Novel Formulations". W Immunological Adjuvants and Vaccines, 133–44. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4757-0283-5_14.
Pełny tekst źródłaStreszczenia konferencji na temat "Immunological adjuvants"
Hamid, Fatima FH, Scott Schactler, Debra Walter, Hardik Amin, Minh Le, David Burkhart, Chenming Zhang i Marco Pravetoni. "Deciphering immunological mechanisms underlying the efficacy of nanoparticle-based vaccines and novel adjuvants against Opioid Use Disorder (OUD)". W ASPET 2023 Annual Meeting Abstracts. American Society for Pharmacology and Experimental Therapeutics, 2023. http://dx.doi.org/10.1124/jpet.122.283050.
Pełny tekst źródłaCircelli, Luisa, Annacarmen Petrizzo, Maria Tagliamonte, Regina Heidenreich, Maria Lina Tornesello, Franco M. Buonaguro i Luigi Buonaguro. "Abstract A044: Immunological effects of a novel RNA-based adjuvant in liver cancer patients". W Abstracts: Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 25-28, 2016; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6066.imm2016-a044.
Pełny tekst źródłaZídek, Zdeněk, Antonín Holý, Daniela Franková, Evžen Buchar i Zdeněk Jiřička. "Inhibition of rat adjuvant-induced arthritis by 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA; Adefovir): Immunological, biochemical and hematological correlates". W XIth Symposium on Chemistry of Nucleic Acid Components. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 1999. http://dx.doi.org/10.1135/css199902180.
Pełny tekst źródłaSchoelch, Sebastian, Conrad Rauber, Moritz Koch, Jürgen Weitz i Peter E. Huber. "Abstract 5389: 3M-011, a toll-like-receptor-7/8 agonist, as immunological adjuvans in combined therapy of gastrointestinal tumors". W Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-5389.
Pełny tekst źródłaCarpanese, D., I. Montagner, A. Dalla Pietà, V. Rossi, A. Penna, G. Zuccolotto, G. Pasut, A. Grigoletto i A. Rosato. "P09.03 Hyaluronic acid as a new immunologic adjuvant in cancer: design of effective preventive and therapeutic vaccination strategies for HER2/neu-positive breast tumors". W iTOC8 – the 8th Leading International Cancer Immunotherapy Conference in Europe, 8–9 October 2021, Virtual Conference. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/jitc-2021-itoc8.53.
Pełny tekst źródłaMittendorf, EA, SA Perez, P. Tzonis, GT Clifton, A. Ardavanis, JP Holmes, E. Lekka i in. "Abstract P2-20-03: Combination Immunotherapy for Breast Cancer Patients: Safety and Immunologic Data from a Phase II Trial Administering a HER2/neu-Derived Peptide vaccine (AE37+GM-CSF) Sequentially or Concurrently with Trastuzumab in the Adjuvant Setting". W Abstracts: Thirty-Third Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 8‐12, 2010; San Antonio, TX. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/0008-5472.sabcs10-p2-20-03.
Pełny tekst źródłaRaporty organizacyjne na temat "Immunological adjuvants"
Clements, John D. Oral Adjuvant Therapy in the Development of Immunological Protection Against Mucosal Pathogens. Fort Belvoir, VA: Defense Technical Information Center, lipiec 1995. http://dx.doi.org/10.21236/ada302243.
Pełny tekst źródła